Ullrich Tim, Schimmöller Lars, Oymanns Mathias, Blondin Dirk, Dietzel Frederic, Kirchner Julian, Arsov Christian, Rabenalt Robert, Albers Peter, Antoch Gerald, Quentin Michael
University Dusseldorf, Medical Faculty, Department of Diagnostic and Interventional Radiology, Dusseldorf, Germany.
University Dusseldorf, Medical Faculty, Department of Urology, Dusseldorf, Germany.
Rofo. 2018 May;190(5):419-426. doi: 10.1055/s-0043-118128. Epub 2017 Sep 21.
To assess the current regional acceptance, valuation, and clinical role of multiparametric MRI (mp-MRI) in prostate cancer diagnostics by patients and physicians.
Of 482 distributed standardized questionnaires, 328 patient and 31 physician questionnaires (urological and general practitioners in and around Düsseldorf) were analyzed over a period of 11 months. Questions were asked concerning general knowledge about prostate cancer, current diagnostic procedures, and knowledge about mp-MRI and MRI-guided biopsy.
70 % of the patients regarded accurate and exact diagnostics of prostate carcinomas as very important and 68 % considered MP-MRI a useful technique. 28 % of the patients with elevated PSA levels and negative transrectal ultrasound-guided biopsy (TRUS-GB) received MP-MRI as a secondary diagnostic. More than half of the patients estimated their overall knowledge about prostate cancer mediocre or worse and wished for more information about MR diagnostics. The majority of physicians (55 %) ordered MP-MRI studies of the prostate and 68 % saw their basic role in secondary diagnostics.
In this regional assessment mp-MRI of the prostate was considered useful by patients and practitioners. Currently, there still is a considerable discrepancy between recommended and the actual number of conducted MP-MRI studies, particularly in patients after previous negative TRUS-GB, although practitioners already see the benefit in this patient collective. Even though the use of prostate MRI is frequently more established than suggested in the current German S3-guideline, its full potential has not yet been exploited. More comprehensive information about the applications and diagnostic benefits of prostate MRI is needed and desired among patients and physicians.
· The use of prostate MRI is frequently more established than suggested in the current German S3-guideline (12/2016). · The full potential of mp-MRI of the prostate has not been exploited. · More information about the clinical benefit and potential of prostate MRI is necessary and desired by patients and clinicians.
· Ullrich T, Schimmöller L, Oymanns M et al. Current Utilization and Acceptance of Multiparametric MRI in the Diagnosis of Prostate Cancer. A Regional Survey. Fortschr Röntgenstr 2018; 190: 419 - 426.
评估患者和医生对多参数磁共振成像（mp-MRI）在前列腺癌诊断中的区域接受度、价值及临床作用。
在11个月的时间里，对482份分发的标准化问卷中的328份患者问卷和31份医生问卷（杜塞尔多夫及其周边地区的泌尿科医生和全科医生）进行了分析。问题涉及前列腺癌的一般知识、当前的诊断程序以及关于mp-MRI和MRI引导活检的知识。
70%的患者认为前列腺癌的准确诊断非常重要，68%的患者认为mp-MRI是一种有用的技术。28%前列腺特异性抗原（PSA）水平升高且经直肠超声引导活检（TRUS-GB）阴性的患者接受了mp-MRI作为二次诊断。超过一半的患者估计他们对前列腺癌的总体了解一般或较差，并希望获得更多关于磁共振诊断的信息。大多数医生（55%）安排了前列腺的mp-MRI检查，68%的医生认为其主要作用在于二次诊断。
在这项区域评估中，患者和从业者认为前列腺mp-MRI是有用的。目前，推荐的mp-MRI检查数量与实际开展的数量之间仍存在相当大的差异，特别是在先前TRUS-GB阴性的患者中，尽管从业者已经看到了这一患者群体的益处。尽管前列腺MRI的应用通常比当前德国S3指南（2016年12月）建议的更为成熟，但其全部潜力尚未得到充分发挥。患者和医生需要并渴望获得更多关于前列腺MRI应用和诊断益处的全面信息。
·前列腺MRI的应用通常比当前德国S3指南（2016年12月）建议的更为成熟。·前列腺mp-MRI的全部潜力尚未得到充分发挥。·患者和临床医生需要并渴望获得更多关于前列腺MRI临床益处和潜力的信息。
·Ullrich T, Schimmöller L, Oymanns M等。多参数MRI在前列腺癌诊断中的当前应用与接受情况。一项区域调查。Fortschr Röntgenstr 2018; 190: 419 - 426。
